Of these, 3,948 (47.91%) psychiatric AE cases were for exenatide, 1,152 (13.98%) for liraglutide, 12 (0.15%) for lixisenatide, 1,833 (22.25%) for dulaglutide, 1,033 (12.54%) for semaglutide, and 262 (3.18%) were for tirzepatide ( Figure 1 )
Eur J Clin Pharmacol 1992;43(6):667-9
In this comprehensive evaluation, the performance of the GPx-Tiron method was directly and systematically compared against two widely recognized reference assays: the traditional GPx-DTNB method and the GPx-CUPRAC method
One drug, though discontinued as a pharmaceutical treatment as a result of potential concerns regarding its propensity to induce depression symptomology in a subset of patients, is of particular interest as a potential nootropic
Well, fast forward first week, second week, third week
Research progress of ferroptosis in glaucoma and optic nerve damage